Sep 2026· Current Research in Microbial Sciences· Vol 11, pp. 100660· 1 citation· 298 references
Medicine
TL;DR
Depletion of SCFA-producing gut bacteria is a consistent feature of Alzheimer’s disease across diverse populations and restoring SCFA-mediated gut-brain communication represents a promising disease-modifying strategy for early AD intervention.
Abstract
Highlights ● Depletion of SCFA-producing gut bacteria is a consistent feature of Alzheimer’s disease across diverse populations.● SCFAs suppress neuroinflammation via GPCR signaling, HDAC inhibition, and metabolic reprogramming of microglia and astrocytes.● SCFAs modulate Aβ deposition, tau pathology, and synaptic integrity through multi-layered regulatory mechanisms.● Restoring SCFA-mediated gut-brain communication represents a promising disease-modifying strategy for early AD intervention.
Short-chain fatty acids (SCFAs), primarily acetate, propionate, and butyrate, are key microbial metabolites generated through the fermentation of indigestible carbohydrates by gut bacteria. Beyond their local actions in the intestinal environment, these metabolites exert far-reaching systemic effects, particularly in s...
Harshpreet Kaur, Joy Das, A. Sah et al.· Current pharmaceutical desig...· 0 citations
By identifying convergent and disease-specific signalling pathways, the review highlights mechanistic nodes of therapeutic relevance and discusses GPCR-centric emerging and other microbiome-targeted strategies aimed at restoring metabolic and signalling homeostasis in neurodegenerative disorders.
Parkinson's disease (PD) is a neurodegenerative disorder characterized mainly by motor dysfunction that severely affects quality of life. In recent years, the gut microbiota and its metabolites, short-chain fatty acids (SCFAs), have become a focus in PD research. These factors are proposed to influence disease progress...
Wan-Hong Wang, Wen-Yu Sun, Li-Hong Ma et al.· Frontiers in Neurology· 0 citations
The gut microbiota acts as an upstream regulator of AD pathology through interconnected molecular mechanisms, and microbiota-targeted interventions have the potential to modulate these pathways and improve cognitive outcomes, although results vary across studies.
Javeria Fatima, Y. Siddique· CNS and Neurological Disorde...· 0 citations
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the CNS whose risk and course are shaped by both genetic and environmental factors, among which the intestinal microbiota has emerged as a key, potentially modifiable contributor. People with MS frequently display altered gut microbiota, charact...
Alicia Sánchez-Sanz, S. Baranzini· Neurology(R) neuroimmunology...· 1 citation
Chronic cerebral hypoperfusion (CCH) is an important contributor to vascular cognitive impairment and neurodegenerative disorders, characterized by neuronal injury, blood–brain barrier (BBB) disruption, neuroinflammation, mitochondrial dysfunction, and synaptic impairment. Increasing evidence suggests that the microbio...
Jun-Chen Si, Pei-Jian Wang, Zhong-Chen Li et al.· Molecular Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.